TFRC and B-cell chronic lymphocytic leukemia: Prognostically, higher TFRC/CD71 expression, and consequently increased ferroptosis sensitivity, is correlated with better clinical outcomes, reinforcing the link between iron metabolism and CLL prognosis.31 Our findings are in line with recent bioinformatic analyses suggesting that high expression of ferroptosis-promoting genes is associated with a favorable prognosis in CLL.52